3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Recruiting
2
Unknown
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
93
Gynecologic
77
Breast
65
Thoracic
47
Head & Neck
16
Other solid neoplasm
7
Genitourinary
6
Tumor-Agnostic
4
Sarcoma
4
CNS
3
Other hematologic neoplasm
2
Lymphoid
2
Endocrine
2
Dermatologic
2
Other neoplasm
1
Other
1
Conditions
Primary Malignant Neoplasm of Ovary
1
Interventions
Cyclophosphamide
5
Decitabine
3
Carboplatin
3
Busulfan
3
Radiotherapy
2
Endoscopy
2
Chemoradiotherapy
2
Capecitabine
2
sintilimab
1
sargramostim
1
liposomal doxorubicin
1
fludarabine phosphate
1
exemestane
1
camrelizumab
1
alethine
1
Watchful Waiting
1
Vincristine
1
Ultrasonography, Doppler
1
Rifampin
1
Proton Therapy
1
Polymerase Chain Reaction
1
Patient Reported Outcome Measures
1
Papanicolaou Test
1
Paclitaxel
1
Observation
1
Mycophenolic Acid
1
Methylation
1
Mass Spectrometry
1
Liver Transplantation
1
Laparoscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Paclitaxel
×
Other neoplasm
×
Clear all
NCT02159820
2014-06-10
DAC and CT
Chinese PLA General Hospital
Phase 2/3
Unknown
500 enrolled